Nuvectis Pharma, Inc.
NVCT
$9.44
-$0.05-0.53%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.94% | -5.23% | -6.93% | 1.77% | -13.30% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -46.38% | -24.18% | -27.20% | 323.73% | -70.94% |
Total Current Assets | 7.51% | -5.42% | -7.18% | 2.76% | -13.82% |
|
|||||
Total Current Assets | 7.51% | -5.42% | -7.18% | 2.76% | -13.82% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 7.51% | -5.42% | -7.18% | 2.76% | -13.82% |
|
|||||
Total Accounts Payable | 10.48% | 22.48% | 4.95% | -36.52% | -20.65% |
Total Accrued Expenses | 57.73% | 3.34% | -0.23% | -6.65% | 102.16% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 40.82% | 9.46% | 1.37% | -18.50% | 25.25% |
|
|||||
Total Current Liabilities | 40.82% | 9.46% | 1.37% | -18.50% | 25.25% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 40.82% | 9.46% | 1.37% | -18.50% | 25.25% |
|
|||||
Common Stock & APIC | 6.37% | 3.47% | 4.05% | 9.02% | 3.32% |
Retained Earnings | -9.33% | -6.61% | -7.58% | -7.69% | -13.91% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -11.63% | -12.27% | -10.65% | 14.93% | -26.88% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.63% | -12.27% | -10.65% | 14.93% | -26.88% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.63% | -12.27% | -10.65% | 14.93% | -26.88% |
|